Frontiers in Aging · Nov 16, 2026
Reduced cerebrospinal fluid NAD+ is associated with idiopathic normal pressure hydrocephalus and senescence-related alterations
By Junji Wei, Ting-Ting Wang, Rui Yin et al.
Idiopathic normal pressure hydrocephalus (iNPH) is a neurological disorder associated with aging, but the specific underlying mechanisms of iNPH are still unclear. Metabolic remodeling plays an important role in the process of aging and the development of various diseases. In order to investigate whether metabolic reprogramming or key metabolites contribute to the pathogenesis of iNPH, cerebrospinal fluid (CSF) samples from iNPH patients and control subjects were collected and subjected to targeted metabolomic and proteomic analyses. Our findings revealed a significant reduction in the levels of nicotinamide adenine dinucleotide (NAD+), a crucial metabolite, in the CSF of iNPH patients. Concomitantly, the expression of senescence-associated secretory phenotype (SASP) factors was notably elevated in the CSF of iNPH patients. We further conducted in vitro experiments and found that application of the NAD+ precursor β-nicotinamide mononucleotide (NMN) could inhibit the senescence of choroid plexus epithelial cells (CPECs) and suppress the levels of SASP factors. These results provide novel insights into the pathogenesis of iNPH and suggest that reduced NAD+ in CSF is associated with iNPH and senescence-related alterations of CPECs. They also suggest a new therapeutic strategy for iNPH.